Armgo Pharma Overview

  • Founded
  • 2004
Founded
  • Status
  • Out of Business
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Out of Business

Armgo Pharma General Information

Description

Developer of small-molecule therapeutics designed to treat debilitating cardiac, skeletal muscular and neurological disorders. The company's small-molecule therapeutics and proprietary drugs are a new class of oral agents that repair calcium leak through the ryanodine receptor calcium-release channel (RyR), which is located on the sarcoplasmic/endoplasmic reticulum of the cell, enabling physicians to help restore the strength of muscle contraction which result in improvements in heart function and skeletal muscle strength of patients.

Contact Information

Website
www.armgo.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Primary Office
  • 777 Old Saw Mill River Road
  • Tarry Town
  • Tarrytown, NY 10591
  • United States
+1 (914) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Armgo Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 15-Jun-2021 0000 Completed Out of Business
4. Grant 17-Apr-2013 0000 Completed Generating Revenue
3. Later Stage VC 24-Aug-2011 000 0000 0000 Completed Generating Revenue
2. Early Stage VC 25-Feb-2008 $500K $9M 000.00 Completed Startup
1. Early Stage VC 16-May-2006 $8.5M $8.5M 000.00 Completed Startup
To view Armgo Pharma’s complete valuation and funding history, request access »

Armgo Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 000,000 00.000000 00 00.00 00.00 00 00.00 0.00
Series A1 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 8,500,000 $0.010000 8% $1 $1 1x $1 26.56%
To view Armgo Pharma’s complete cap table history, request access »

Armgo Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial